{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:18:23Z","timestamp":1789161503505,"version":"build-2803163510"},"reference-count":102,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Genetic cardiomyopathies represent a wide spectrum of inherited diseases and constitute an important cause of morbidity and mortality among young people, which can manifest with heart failure, arrhythmias, and\/or sudden cardiac death. Multiple underlying genetic variants and molecular pathways have been discovered in recent years; however, assessing the pathogenicity of new variants often needs in-depth characterization in order to ascertain a causal role in the disease. The application of human induced pluripotent stem cells has greatly helped to advance our knowledge in this field and enabled to obtain numerous in vitro patient-specific cellular models useful to study the underlying molecular mechanisms and test new therapeutic strategies. A milestone in the research of genetically determined heart disease was the introduction of genomic technologies that provided unparalleled opportunities to explore the genetic architecture of cardiomyopathies, thanks to the generation of isogenic pairs. The aim of this review is to provide an overview of the main research that helped elucidate the pathophysiology of the most common genetic cardiomyopathies: hypertrophic, dilated, arrhythmogenic, and left ventricular noncompaction cardiomyopathies. A special focus is provided on the application of gene-editing techniques in understanding key disease characteristics and on the therapeutic approaches that have been tested.<\/jats:p>","DOI":"10.3390\/jcm10051149","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T21:36:21Z","timestamp":1615325781000},"page":"1149","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genetic Cardiomyopathies: The Lesson Learned from hiPSCs"],"prefix":"10.3390","volume":"10","author":[{"given":"Ilaria","family":"My","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy"},{"name":"Humanitas Clinical and Research Center\u2014IRCCS, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Di Pasquale","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center\u2014IRCCS, Rozzano, 20089 Milan, Italy"},{"name":"Institute of Genetic and Biomedical Research (IRGB)\u2014UOS of Milan, National Research Council (CNR), 20138 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: A position paper from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Polovina","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Burridge, P.W., Holmstr\u00f6m, A., and Wu, J.C. (2015). Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells. Curr. Protoc. Hum. Genet., 87.","DOI":"10.1002\/0471142905.hg2103s87"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","article-title":"Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome","volume":"363","author":"Moretti","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_5","first-page":"808","article-title":"Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome","volume":"465","author":"Sevilla","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.bbamcr.2016.03.003","article-title":"High throughput physiological screening of iPSC-derived cardiomyocytes for drug development","volume":"1863","author":"Lemons","year":"2016","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"107925","DOI":"10.1016\/j.celrep.2020.107925","article-title":"Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes","volume":"32","author":"Feyen","year":"2020","journal-title":"Cell Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.jacc.2016.08.079","article-title":"Clinical and Mechanistic Insights into the Genetics of Cardiomyopathy","volume":"68","author":"Burke","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11886-017-0828-z","article-title":"Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research","volume":"19","author":"Goedel","year":"2017","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_10","first-page":"e000043","article-title":"Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association","volume":"11","author":"Musunuru","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy","volume":"76","author":"Ommen","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gene.2015.11.048","article-title":"Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy","volume":"577","author":"Bottillo","year":"2016","journal-title":"Gene"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu205","article-title":"Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells","volume":"104","author":"Han","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.stemcr.2016.04.006","article-title":"Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes","volume":"6","author":"Pioner","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jacbts.2018.08.008","article-title":"Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells","volume":"3","author":"Yang","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1093\/eurheartj\/ehy249","article-title":"CRISPR\/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy","volume":"39","author":"Mosqueira","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1152\/physiolgenomics.00021.2020","article-title":"Silencing of MYH7 ameliorates disease phenotypes in human iPSC-cardiomyocytes","volume":"52","author":"Dainis","year":"2020","journal-title":"Physiol. Genom."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2020.06.003","article-title":"Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics","volume":"145","author":"Bhagwan","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejmg.2010.07.007","article-title":"Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy","volume":"53","author":"Millat","year":"2010","journal-title":"Eur. J. Med Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCGENETICS.108.821314","article-title":"Prevalence of Sarcomere Protein Gene Mutations in Preadolescent Children With Hypertrophic Cardiomyopathy","volume":"2","author":"Kaski","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1034\/j.1399-0004.2003.00151.x","article-title":"Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy","volume":"64","author":"Erdmann","year":"2003","journal-title":"Clin. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e001263","DOI":"10.1161\/JAHA.114.001263","article-title":"Endothelin-1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy\u2013Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes","volume":"3","author":"Tanaka","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/jcmm.12356","article-title":"Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes","volume":"18","author":"Dambrot","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.celrep.2015.09.025","article-title":"Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function","volume":"13","author":"Birket","year":"2015","journal-title":"Cell Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/1684792","article-title":"Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or\u03b1-Tropomyosin Mutation for Hypertrophic Cardiomyopathy","volume":"2016","author":"Ojala","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yjmcc.2016.09.004","article-title":"Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes","volume":"99","author":"Helms","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.omtn.2017.05.008","article-title":"Evaluation of MYBPC3 trans -Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes","volume":"7","author":"Prondzynski","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.118.034624","article-title":"A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay","volume":"139","author":"Seeger","year":"2019","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.stemcr.2018.11.015","article-title":"A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations","volume":"12","author":"Cohn","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.yjmcc.2017.12.002","article-title":"Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes","volume":"114","author":"Wang","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12265-019-09873-6","article-title":"Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations","volume":"12","author":"Zhou","year":"2019","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.stemcr.2018.10.006","article-title":"Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy\/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits","volume":"11","author":"Smith","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e11115","DOI":"10.15252\/emmm.201911115","article-title":"Disease modeling of a mutation in \u03b1-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy","volume":"11","author":"Prondzynski","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","article-title":"Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR\/Cas9 and Human-Induced Pluripotent Stem Cells","volume":"138","author":"Ma","year":"2018","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1093\/eurheartj\/ehw160","article-title":"ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy","volume":"37","author":"Phelan","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/j.celrep.2016.11.066","article-title":"Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis","volume":"17","author":"Hinson","year":"2016","journal-title":"Cell Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.hrthm.2017.09.024","article-title":"CRISPR correction of the PRKAG2 gene mutation in the patient\u2019s induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities","volume":"15","author":"Jehuda","year":"2018","journal-title":"Heart Rhythm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/eurheartj\/ehz326","article-title":"Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients","volume":"40","author":"Wu","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCRESAHA.118.314202","article-title":"Identifying the Transcriptome Signatures of Calcium Channel Blockers in Human Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes","volume":"125","author":"Lam","year":"2019","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00424-018-2214-0","article-title":"Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes\u2014A systematic review","volume":"471","author":"Eschenhagen","year":"2019","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","article-title":"Genetic evaluation of cardiomyopathy: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Hershberger","year":"2018","journal-title":"Genet. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41569-019-0284-0","article-title":"Genetics of dilated cardiomyopathy: Practical implications for heart failure management","volume":"17","author":"Rosenbaum","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.aaa5458","article-title":"Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy","volume":"349","author":"Hinson","year":"2015","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"562","DOI":"10.15252\/emmm.201505047","article-title":"Antisense-mediated exon skipping: A therapeutic strategy for titin-based dilated cardiomyopathy","volume":"7","author":"Gramlich","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Schick, R., Mekies, L.N., Shemer, Y., Eisen, B., Hallas, T., Ben Jehuda, R., Ben-Ari, M., Szantai, A., Willi, L., and Shulman, R. (2018). Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0205719"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2011-12-5-222","article-title":"The lamin protein family","volume":"12","author":"Dittmer","year":"2011","journal-title":"Genome Biol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Crasto, S., My, I., and Di Pasquale, E. (2020). The Broad Spectrum of LMNA Cardiac Diseases: From Molecular Mechanisms to Clinical Phenotype. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00761"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.18632\/aging.100277","article-title":"Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A\/C","volume":"3","author":"Ho","year":"2011","journal-title":"Aging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.18632\/aging.100503","article-title":"Modeling of lamin A\/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells","volume":"4","author":"Siu","year":"2012","journal-title":"Aging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09929-w","article-title":"The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy","volume":"10","author":"Salvarani","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_54","first-page":"335","article-title":"Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy","volume":"572","author":"Lee","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Shah, D., Virtanen, L., Prajapati, C., Kiamehr, M., Gullmets, J., West, G., Kreutzer, J., Pekkanen-Mattila, M., Heli\u00f6, T., and Kallio, P. (2019). Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells. Cells, 8.","DOI":"10.3390\/cells8060594"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1083\/jcb.201902117","article-title":"Chromatin compartment dynamics in a haploinsufficient model of cardiac laminopathy","volume":"218","author":"Bertero","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O.J., Navarrete, E.G., Hu, S., Wang, L., and Lee, A. (2012). Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy. Sci. Transl. Med., 4.","DOI":"10.1126\/scitranslmed.3003552"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.stem.2015.04.020","article-title":"Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised \u03b2-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy","volume":"17","author":"Wu","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1152\/ajpheart.00162.2016","article-title":"A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation","volume":"311","author":"Broughton","year":"2016","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56597-3","article-title":"Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients","volume":"10","author":"Dai","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9276","DOI":"10.1073\/pnas.1714538115","article-title":"Telomere shortening is a hallmark of genetic cardiomyopathies","volume":"115","author":"Chang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1161\/CIRCULATIONAHA.118.035028","article-title":"Functional Annotation of TNNT2 Variants of Uncertain Significance With Genome-Edited Cardiomyocytes","volume":"138","author":"Lv","year":"2018","journal-title":"Circulation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/CIRCRESAHA.116.309948","article-title":"A Comprehensive TALEN-Based Knockout Library for Generating Human-Induced Pluripotent Stem Cell\u2013Based Models for Cardiovascular Diseases","volume":"120","author":"Karakikes","year":"2017","journal-title":"Circ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Levitas, A., Muhammad, E., Zhang, Y., Gil, I.P., Serrano, R., Diaz, N., Arafat, M., Gavidia, A.A., Kapiloff, M.S., and Mercola, M. (2020). A Novel Recessive Mutation in SPEG Causes Early Onset Dilated Cardiomyopathy. PLoS Genet., 16.","DOI":"10.1371\/journal.pgen.1009000"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/hmg\/dds556","article-title":"Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing","volume":"22","author":"Tse","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yjmcc.2019.11.147","article-title":"Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs","volume":"138","author":"Stroik","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yjmcc.2018.05.007","article-title":"Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes","volume":"119","author":"Ceholski","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/hmg\/ddv468","article-title":"Modeling structural and functional deficiencies ofRBM20familial dilated cardiomyopathy using human induced pluripotent stem cells","volume":"25","author":"Wyles","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yjmcc.2017.09.008","article-title":"Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes","volume":"113","author":"Tiburcy","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09483-5","article-title":"Dynamics of genome reorganization during human cardiogenesis reveal an RBM20-dependent splicing factory","volume":"10","author":"Bertero","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Judge, L.M., Perez-Bermejo, J.A., Truong, A., Ribeiro, A.J., Yoo, J.C., Jensen, C.L., Mandegar, M.A., Huebsch, N., Kaake, R.M., and So, P.-L. (2017). A BAG3 chaperone complex maintains cardiomyocyte function during proteotoxic stress. JCI Insight, 2.","DOI":"10.1172\/jci.insight.94623"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"McDermott-Roe, C., Lv, W., Maximova, T., Wada, S., Bukowy, J., Marquez, M., Lai, S., Shehu, A., Benjamin, I., and Geurts, A. (2019). Investigation of a dilated cardiomyopathy-associated variant in BAG3 using genome-edited iPSC-derived cardiomyocytes. JCI Insight, 4.","DOI":"10.1172\/jci.insight.128799"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41551-019-0348-9","article-title":"Combinatorial interactions of genetic variants in human cardiomyopathy","volume":"3","author":"Deacon","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0140-6736(09)60256-7","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"373","author":"Basso","year":"2009","journal-title":"Lancet"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/eurheartj\/ehs226","article-title":"Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy","volume":"34","author":"Ma","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCGENETICS.113.000188","article-title":"Modeling of Arrhythmogenic Right Ventricular Cardiomyopathy With Human Induced Pluripotent Stem Cells","volume":"6","author":"Caspi","year":"2013","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_78","first-page":"105","article-title":"Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs","volume":"494","author":"Kim","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e98133","DOI":"10.15252\/embj.201798133","article-title":"Interplay of cell\u2013cell contacts and RhoA\/ MRTF -A signaling regulates cardiomyocyte identity","volume":"37","author":"Dorn","year":"2018","journal-title":"EMBO J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1253\/circj.CJ-15-0363","article-title":"Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells","volume":"79","author":"Wen","year":"2015","journal-title":"Circ. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/eurheartj\/ehx011","article-title":"Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy\/dysplasia: From a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome","volume":"38","author":"Akdis","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Asimaki, A., Kapoor, S., Plovie, E., Arndt, A.K., Adams, E., Liu, Z., James, C.A., Judge, D.P., Calkins, H., and Churko, J. (2014). Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy. Sci. Transl. Med., 6.","DOI":"10.1126\/scitranslmed.3008008"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/europace\/euy042","article-title":"Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy","volume":"20","author":"Zhao","year":"2018","journal-title":"Europace"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Buljubasic, F., El-Battrawy, I., Lan, H., Lomada, S.K., Chatterjee, A., Zhao, Z., Li, X., Zhong, R., Xu, Q., and Huang, M. (2020). Nucleoside Diphosphate Kinase B Contributes to Arrhythmogenesis in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020486"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/cvw234","article-title":"Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia\/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis","volume":"113","author":"Riele","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Ng, R., Manring, H., Papoutsidakis, N., Albertelli, T., Tsai, N., See, C.J., Li, X., Park, J., Stevens, T.L., and Bobbili, P.J. (2019). Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation. JCI Insight, 4.","DOI":"10.1172\/jci.insight.128643"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.119.040366","article-title":"Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3\u03b2","volume":"140","year":"2019","journal-title":"Circulation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.7150\/thno.45172","article-title":"Intracellular calcium current disorder and disease phenotype in OBSCN mutant iPSC-based cardiomyocytes in arrhythmogenic right ventricular cardiomyopathy","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jacc.2017.12.019","article-title":"Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy","volume":"71","author":"Caliskan","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCGENETICS.109.903898","article-title":"The Importance of Genetic Counseling, DNA Diagnostics, and Cardiologic Family Screening in Left Ventricular Noncompaction Cardiomyopathy","volume":"3","author":"Hoedemaekers","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1161\/CIRCULATIONAHA.107.746164","article-title":"Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction","volume":"117","author":"Klaassen","year":"2008","journal-title":"Circulation"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ncb3411","article-title":"iPSC-derived cardiomyocytes reveal abnormal TGF-\u03b2 signalling in left ventricular non-compaction cardiomyopathy","volume":"18","author":"Kodo","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.cell.2016.11.033","article-title":"Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis","volume":"167","author":"Ang","year":"2016","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.aat5056","article-title":"Oligogenic inheritance of a human heart disease involving a genetic modifier","volume":"364","author":"Gifford","year":"2019","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nbt.3271","article-title":"Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells","volume":"33","author":"Birket","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_96","first-page":"239","article-title":"Advanced maturation of human cardiac tissue grown from pluripotent stem cells","volume":"556","author":"Ma","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.stem.2020.05.004","article-title":"Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease","volume":"26","author":"Giacomelli","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.stem.2020.10.003","article-title":"BMP10 Signaling Promotes the Development of Endocardial Cells from Human Pluripotent Stem Cell-Derived Cardiovascular Progenitors","volume":"28","author":"Mikryukov","year":"2021","journal-title":"Cell Stem Cell"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.stem.2017.07.003","article-title":"Human Pluripotent Stem Cell-Derived Atrial and Ventricular Cardiomyocytes Develop from Distinct Mesoderm Populations","volume":"21","author":"Lee","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nbt.3745","article-title":"Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker","volume":"35","author":"Protze","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.cell.2018.11.042","article-title":"A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling","volume":"176","author":"Zhao","year":"2019","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Drakhlis, L., Biswanath, S., Farr, C.-M., Lupanow, V., Teske, J., Ritzenhoff, K., Franke, A., Manstein, F., Bolesani, E., and Kempf, H. (2021). Human heart-forming organoids recapitulate early heart and foregut development. Nat. Biotechnol., 1\u201310.","DOI":"10.1038\/s41587-021-00960-1"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/5\/1149\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:35:45Z","timestamp":1760160945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/5\/1149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":102,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["jcm10051149"],"URL":"https:\/\/doi.org\/10.3390\/jcm10051149","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]}}}